The ability of cloned Rous sarcoma virus (RSV) DNA encoding the v-src oncogene to neoplasticafly transform normal, diploid Syrian hamster embryo (SHE) cells was examined. Transfection of RSV DNA into early passage SHE cells resulted in a low but significant number of tumors when treated cells were injected into nude mice. Tumors formed with a low frequency (two tumors out of ten sites injected) and only after a long latency period (14 weeks). In contrast to the normal SHE cells, several different carcinogen-induced preneoplastic immortal SHE cell lines were highly susceptible to transformation by the v-src oncogene to the neoplastic phenotype. Tumors formed with high efficiency and a short latency period (<3 weeks). Further studies were performed to determine the basis for the inefficient transformation of the normal SHE cells. NeoR clones isolated after cotransfection of SHE cells with pSV2-neo and RSV DNAs were neither morphologically altered nor immortal and did not contain detectable levels of the v-src gene product. These results suggest that neoplastic transformation by v-src DNA in the normal cells is initially suppressed. However, cells from a v-src-induced tumor expressed v-src RNA, and antibody to v-src protein precipitated from the tumor cells a 60,000-molecular-weight protein which displayed protein kinase activity. Karyotypic analyses confirmed that the tumor was derived from Syrian hamster cells and suggested that it was clonal in nature. These results indicate that the v-src oncogene was primarily responsible for neoplastic transformation of SHE cells. In contrast to the results with the v-src oncogene, our previous studies showed that v-Ha-ras oncogene alone is unable to induce neoplastic transformation of SHE cells. Furthermore, the v-myc oncogene was able to complement v-Ha-ras to neoplastically transform SHE cells, while cotransfection with v-src plus v-myc did not increase the incidence of tumors.To understand the significance of oncogenes in neoplastic development, it is necessary to define the role of specific oncogenes in different steps of the multistep process of neoplastic progression. One experimental approach to this problem is the transfection of normal or preneoplastic cells with specific oncogenes or combinations of oncogenes to determine whether neoplastic transformation can be induced by this method. For example, Land et al. (23) To determine the universality of results obtained with a given system, it is important to compare the effects of transfection of oncogenes into different target cells. We have been studying the neoplastic progression of Syrian hamster embryo (SHE) cells in culture. This system has a number of advantages for studying the role of oncogenes in a multistep process of carcinogenesis. The normal cells have a stable karyotype and show a lower frequency of spontaneous transformation than do mouse, rat, or Chinese hamster fibroblasts (4). However, a variety of chemical carcinogens can induce morphologically transformed cells which can be isolated and cloned. The...